Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764985 · ClinicalTrials.gov registry record
Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis
A clinical trial of Syncope, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- 540
- Enrollment target
- 1
- Study location
NCT00764985: Completed study of Syncope, sponsored by St. Luke's-Roosevelt Hospital Center.
NCT00764985 is a study of Syncope that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 540 participants, below the 802-participant average among 11 other Syncope trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00764985, a study of Syncope, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- 540 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators want to look at how patients admitted after passing out (syncope) or nearly passing out (pre-syncope) do after going home and how many of them remain free of symptoms of syncope or pre-syncope.
Conditions Studied
Study Locations (1)
New York
- St. Luke's-Roosevelt Hospital Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-07 |
What the finished NCT00764985 record still lists
NCT00764985 is an observational study that tracks outcomes without assigning an intervention. The registered 540 participants enrollment target is mid-sized for trials with a published cap, below the 802-participant average among 11 other Syncope trials with a reported enrollment target (33% lower).
The record links to 1 condition, with Syncope appearing as the primary indexed condition, and to 0 interventions.
NCT00764985 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00764985 about?
NCT00764985 is a clinical study titled "Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis". The investigators want to look at how patients admitted after passing out (syncope) or nearly passing out (pre-syncope) do after going home and how many of them remain free of symptoms of syncope or pre-syncope.
What is the current status of trial NCT00764985?
This trial is currently completed. The enrollment target is 540 participants. The study started on 2008-06. Estimated completion is 2010-07.
What conditions does trial NCT00764985 study?
This clinical trial studies the following conditions: Syncope.
Who is sponsoring clinical trial NCT00764985?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00764985 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Syncope
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00764985's enrollment target sits among peer trials
540 6th of 11 higher than 6 of 11 other Syncope trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Syncope trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Z Stitch Early Bed Rest Assessment Study
RECRUITING · NA
-
Genetic Markers of Cardiovascular Disease in Epilepsy
RECRUITING
-
BAsel Syncope EvaLuation (BASEL IX) Study
ACTIVE NOT RECRUITING
-
Pediatric Adhesion and New Dermal Approach Study
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
- NCT05429892 · 540 participants · NA
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
- NCT05549297 · 540 participants · Phase 3
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia